Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-004116
Filing Date
2025-06-26
Accepted
2025-06-26 07:30:04
Documents
2
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_062625.htm 6-K 6012
2 PRESS RELEASE exh_991.htm EX-99.1 11094
  Complete submission text file 0001171843-25-004116.txt   18338
Mailing Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7
Business Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 251075064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)